Use of intravenous buprenorphine microdosing to initiate medication for opioid use disorder in a patient with co-occurring pain: case report

被引:1
|
作者
Bodnar, Alia [1 ]
Diffenderffer, Christine [1 ]
Jablonski, Lindsay A. [2 ]
Bai, Eric [1 ]
Stewart, Rosalyn W. [1 ]
机构
[1] Johns Hopkins Univ, Dept Med, 601 N Caroline St,Suite 7-143, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD USA
关键词
Buprenorphine microdosing; low-dose buprenorphine induction; opioid use disorder; acute pain; case report;
D O I
10.1080/10550887.2023.2285201
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
IntroductionBuprenorphine is used to treat opioid use disorder (OUD). However, therapy is often disrupted during acute pain episodes, and re-initiation is often deferred due to intolerable interruption in opioid analgesics. This case report describes a unique strategy for inducing buprenorphine without stopping opioid analgesics.CaseOne patient with OUD and acute pain was initiated on buprenorphine using intravenous microdosing without precipitated withdrawal or pain exacerbation. Full agonist opioids were successfully weaned after discharge and the patient was linked with a community-based treatment program.ConclusionThis case describes use of intravenous buprenorphine to treat OUD and acute pain without adverse consequences.
引用
收藏
页码:567 / 571
页数:5
相关论文
共 50 条
  • [21] Managing Opioid Use Disorder and Co-Occurring Posttraumatic Stress Disorder Among Veterans
    Snow, Rhonda
    Wynn, Stephanie T.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (06) : 36 - 42
  • [22] Multicomponent Psychosocial Intervention to Augment Standard Medication Management for Co-Occurring Opioid Use and Mental Health Disorder
    Gonzalez, Gerardo
    David, Smelson
    Li, Wenjun
    Olmstead, Todd
    Shaffer, Paige
    Jennifer, Harter
    Helm, Abigail
    Kendra, Caputo
    Eleni, Kachadoorian
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [23] Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders
    O'Brien, Peggy
    Henke, Rachel Mosher
    Schaefer, Mary Beth
    Lin, Janice
    Creedon, Timothy B.
    DRUG AND ALCOHOL DEPENDENCE, 2020, 217
  • [24] Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report
    South, Anna-Maria
    Oller, Devin
    Lofwall, Michelle
    Fanucchi, Laura C.
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (01) : 86 - 89
  • [25] Co-Occurring Schizophrenia and Toluene Use Disorder: A Case Report and Qualitative Literature Review
    Kenyon, Laura
    Constantino, Eduardo
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 253 - 254
  • [26] Acute Pain Management for Patients Maintained on Sublingual Buprenorphine as Medication for Opioid Use Disorder
    Haines, Alexander J.
    Wood, Katlyn C.
    Costello, Jennifer L.
    Tawil, Tara
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (06) : 662 - 669
  • [27] Co-occurring alcohol use disorder and schizophrenia
    Drake, RE
    Mueser, KT
    ALCOHOL RESEARCH & HEALTH, 2002, 26 (02) : 99 - 102
  • [28] Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder
    Varley, Allyson L.
    Lappan, Sara
    Jackson, Juliet
    Goodin, Burel R.
    Cherrington, Andrea L.
    Copes, Heith
    Hendricks, Peter S.
    JOURNAL OF DUAL DIAGNOSIS, 2020, 16 (02) : 239 - 249
  • [29] Schizophrenia and co-occurring substance use disorder
    Green, Alan I.
    Drake, Robert E.
    Brunette, Mary F.
    Noordsy, Douglas L.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (03): : 402 - 408
  • [30] What is Buprenorphine? How and why is it use for pain and for opioid use disorder?
    Reznikoff, Charles
    PAIN MANAGEMENT NURSING, 2024, 25 (02) : E157 - E157